J. O’Shaughnessy

Transforming growth factor-beta1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer.

Lalage M. Wakefield, John J. Letterio, T Chen et al. · PubMed · 1995 · 159 citations

Breast Oncology, Normal Human Plasma, Immunology +18

Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trials.

J. O’Shaughnessy, R. Wittes, Gerard Burke et al. · Journal of Clinical Oncology · 1991 · 84 citations

Investigational Anticancer Agents, New Drug, Clinical Trial Design +14

Gemcitabine plus paclitaxel (GT) versus paclitaxel (T) as first-line treatment for anthracycline pre-treated metastatic breast cancer (MBC): Quality of life (QoL) and pain palliation results from the global phase III study

Carol M. Moinpour, Juan Wu, Gary Donaldson et al. · Journal of Clinical Oncology · 2004 · 43 citations

Pain Therapy, Pain Disorders, Pain Palliation Results +24

Phase I study of paclitaxel in combination with cyclophosphamide and granulocyte colony-stimulating factor in metastatic breast cancer patients.

Anthony W. Tolcher, Kenneth H. Cowan, Marianne Noone et al. · Journal of Clinical Oncology · 1996 · 29 citations

Advancing alternative methods to reduce animal testing

Chad P. Nelson, Paul C. Brown, Suzanne Fitzpatrick et al. · Science · 2024 · 21 citations